Menu

Generate Biomedicines, Inc. GENB

Full chart Compare
Set alert

Price alert · GENB

All alert types
13.06 USD +0.49 (+3.90%)

At closeNov 6, 2026, 4:00 PM EST

13.06 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

12.47 Day range 13.17
11.21 52-week range 20.38
YTD
+3.24%
1 year
+3.24%

Revenue & Expenses

Other Income → Expenses: $32.07MExpenses → Selling, General & Admin: $42.26MExpenses → Research & Development: $224.70MExpenses → Income Tax: $163.00KGross Profit → Expenses: $31.89MRevenue → Gross Profit: $31.89MNet Loss → Expenses: $203.15MOther Income$32.07MGross Profit$31.89MNet Loss$203.15MExpenses$267.12MSelling, General & Admin$42.26MResearch & Development$224.70MIncome Tax$163.00KRevenue$31.89M

Latest period ending Dec 31, 2025 · select a line to chart its full history

GENB annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
31.89M20.46M
31.89M20.46M
-235.06M-196.94M
-203.15M-173.77M
-7.57-6.66
GENB annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
121.99M177.70M
330.18M518.26M
141.55M163.50M
68.53M76.97M
-608.73M-433.95M
GENB annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-200.62M-117.75M
116.77M-57.73M
28.06M91.33M
-3.51M-3.44M
-55.79M-84.15M